Robert Andrade - 15 Jan 2026 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Andrade
Issuer symbol
FENC
Transactions as of
15 Jan 2026
Net transactions value
$0
Form type
4
Filing time
15 Jan 2026, 16:05:04 UTC
Previous filing
07 Jan 2026
Next filing
23 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Andrade Robert CHIEF FINANCIAL OFFICER C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK /s/ Robert Andrade 15 Jan 2026 0001468308

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $24,500 +10,000 +5.2% $2.45 201,100 15 Jan 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Options Exercise $24,500 -10,000 -1.2% $2.45 826,567 15 Jan 2026 Options 10,000 $2.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.